| Financial Year |
March 31 2023 |
| Monetary Funds |
6,006,928,311.71 |
| Held-for-trading Financial Assets |
81,457,262.51 |
| Notes Receivable |
-- |
| Accounts Receivable |
25,208,634.45 |
| Advances to Suppliers |
178,374,175.38 |
| Other Receivables |
87,967,153.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,434,855,132.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,847,189,566.09 |
| Total Current Assets |
17,701,655,228.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,647,526,420.91 |
| Investment Properties |
3,915,230,310.76 |
| Fixed Assetes |
464,213,084.53 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,512,399.09 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,349,946.20 |
| Deferred Income Tax Assets |
62,144,828.40 |
| Other Non-Current Assets |
2,428,667.90 |
| Sub-Total of Non-Current Assets |
6,303,835,188.58 |
| Total Assets |
24,005,490,417.02 |
| Short-Term Loans |
45,000,000.00 |
| Trading Financial liabilities |
32,720.00 |
| Notes Payable |
-- |
| Accounts Payable |
1,483,066,692.28 |
| Accounts Received In Advance |
45,157,295.08 |
| Employee Compensation Payable |
28,185,327.04 |
| Taxes Payable |
191,090,238.49 |
| Interest Payable |
-- |
| Dividend Payable |
19,916,410.16 |
| Other payables |
1,354,727,670.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
106,800,929.47 |
| Other Current Liabilities |
7,973,838,515.28 |
| Sub-Total of Current Liabilities |
13,945,773,793.41 |
| Long-term Loans |
2,889,688,195.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
93,210,111.57 |
| Other Non-Current Liabilities |
2,389,059,573.07 |
| Sub-Total of Non-Current Liabilities |
5,440,711,782.39 |
| Total Liabilities |
19,386,485,575.80 |
| Paid-In Capital(Or Share Stock) |
673,396,786.00 |
| Capital Surplus |
902,640,279.28 |
| Surplus Reserve |
364,976,349.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,436,666,046.27 |
| Minority Stockholder's Interest |
234,322,834.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,384,682,006.93 |
| Owner's Equity（Stockholder's Equity） |
4,619,004,841.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
24,005,490,417.02 |
